mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses
In a recent study published in the journal Science, researchers observed differential effector functions of antibodies elicited by Pfizer’s BNT162b2 and Moderna’s messenger ribonucleic acid (mRNA)-1273 coronavirus disease 2019 (COVID-19) vaccines.
Source: news-medical.net